Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (5574)	1/5/2007 1:55:13 PM
From: freelyhovering	Read Replies (1) \| Respond to of 12215

I did see it Rick. Thanks. I briefly visited the site that Chris suggested and saw the article critical of scientists who hype supplements. By the way, Ames was a principle in the development of Juvenon. I don't know if he is part of the hype like Andrew Weil or not. Here are his comments from a Newsweek article in January '06: "The pill is sold by Juvenon [a company Ames formed to license the combination of cell-rejuvenating supplements]. But I won't take money from the company. It all goes to clinical trials. I didn't feel very different after taking the pill. But I am a pretty spry 77. We've just completed a human trial now. The data hasn't been released publicly yet, but I can tell you: it was successful." I have not been able to find the results of the study that Ames mentioned. I have e-mailed the company a couple of times and they say that a planned study, announced January '06 is still delayed. No reasons were given. Curious. Myron